Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Habitual consumption of significant amounts ( . 10% energy) of dietary fructose contributes to TG elevations, particularly in people with HTG.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The impact of fructose/sucrose intake on HDL-C does not seem different from that of other refined carbohydrates.158,159”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sucrose, a disaccharidecontaining glucose and fructose, represents an important source of fructose in the diet. 158,175”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fructose has emerged as a potent activator of carbohydrate response element-binding protein (ChREBP), which is particularly relevant in the context of MASLD, given the global rise in fructose consumption that parallels the increasing prevalence of MASLD [78- 82].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“dietary fructose contributes to TG elevations; these effects are dose dependent and become clinically relevant when the intake is .10%energy daily-with a habitual fructose consumption between 15 and 20% of the energy intake, plasma TG increases as much as 30 -40%.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [76]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
A new predictive equation for resting energy expenditure in healthy individuals
Mifflin, M., St Jeor, S., Hill, L., Scott, B., Daugherty, S., & Koh, Y. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.2.241 · Cited by 2,544 · cited 1×
“calculated by the Mifflin equation (67), with an adjustment of 1.”
MethodNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Diacylglycerol is a known activator of novel PKC (51), and increases of both diacylglycerol and novel PKC activity are associated with lipid-induced insulin resistance (52, 53).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundConway, J. M., Ingwersen, L. A., Vinyard, B. T., & Moshfegh, A. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1171 · Cited by 820
Research works printed but not linked: 1
- Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42 :A39.
Cited by
Items 701–800 of 1,008
EFSA Panel on Dietetic Products, N. A. A. (. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2223 · Cited by 37
Shi, B., Feng, D., Sagnelli, M., Jiao, J., Sun, X., Wang, X., & Li, D. (2019) · Human Reproduction · doi:10.1093/humrep/dez239 · Cited by 32
Villaño, D., Masoodi, H., Marhuenda, J., García‐Viguera, C., & Zafrilla, P. (2021) · LWT · doi:10.1016/j.lwt.2021.111173 · Cited by 33
Aoun, R., Chokor, F. A. Z., Taktouk, M., Nasrallah, M., Isma’eel, H., Tamim, H., & Nasreddine, L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00800-5 · Cited by 34
Fructose and Fructans: Opposite Effects on Health?
Bartolomeo, F. D., & den Ende, W. V. (2015) · Plant Foods for Human Nutrition · doi:10.1007/s11130-015-0485-6 · Cited by 33
Sickeningly Sweet: Does Sugar Cause Type 2 Diabetes? Yes
Lustig, R. H. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.01.004 · Cited by 33
Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease
Vittorio, J., & Lavine, J. E. (2020) · F1000Research · doi:10.12688/f1000research.24198.1 · Cited by 35
The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose?
McCarty, M. F., & DiNicolantonio, J. J. (2014) · Open Heart · doi:10.1136/openhrt-2014-000103 · Cited by 34
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30
Genetic-related and carbohydrate-related factors affecting liver fat accumulation
Goran, M. I., Walker, R., & Allayee, H. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283544477 · Cited by 30
“[5] examined overweight and obese individuals who consumed glucose or fructose sweetened beverages for 10 weeks at 25% of daily energy requirements under closely controlled conditions.”
BackgroundCorte, K. W. D., Bosler, T., McClure, C., Buyken, A. E., LeCheminant, J. D., Schwingshackl, L., & Corte, D. D. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100413 · Cited by 38
Kovačević, S., Brkljačić, J. M., Matić, G. M., & Elaković, I. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0644-1 · Cited by 33
The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins
Nakajima, K., Tokita, Y., Tanaka, A., & Takahashi, S. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.05.004 · Cited by 34
Self-citationCeciliano, T. C., Dutra, R. R., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105399 · Cited by 31
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck, P. J., Morris, J. K., & Stanford, J. A. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s388579 · Cited by 37
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle
Stefanis, D. D., Mastrocola, R., Nigro, D., Costelli, P., & Aragno, M. (2015) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/s00394-015-1086-8 · Cited by 30
Regulation of low-density lipoprotein subfractions by carbohydrates
Gerber, P. A., & Berneis, K. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283545a6d · Cited by 30
Medicines and Vegetable Oils as Hidden Causes of Cardiovascular Disease and Diabetes
Okuyama, H., Langsjoen, P. H., Ohara, N., Hashimoto, Y., Hamazaki, T., Yoshida, S., Kobayashi, T., & Langsjoen, A. M. (2016) · Pharmacology · doi:10.1159/000446704 · Cited by 36
Zhang, G., Byun, H. R., Ying, Z., Blencowe, M., Zhao, Y., Hong, J. S., Shu, L., Krishnan, K. C., Gómez‐Pinilla, F., & Yang, X. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165569 · Cited by 33
Silbernagel, G., Lütjohann, D., Machann, J., Meichsner, S., Kantartzis, K., Schick, F., Häring, H., Stefan, N., & Fritsche, A. (2011) · Experimental Diabetes Research · doi:10.1155/2012/361863 · Cited by 33
Rattanavichit, Y., Chukijrungroat, N., & Saengsirisuwan, V. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00230.2016 · Cited by 34
Dietary determinants of obesity.
Du, H., & Feskens, E. J. M. (2010) · PubMed · doi:10.2143/ac.65.4.2053895 · Cited by 46
Gallagher, C., Keogh, J. B., Pedersen, E., & Clifton, P. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.129866 · Cited by 32
A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma
Dewdney, B., Roberts, A. A., Qiao, L., George, J., & Hebbard, L. (2020) · Biomolecules · doi:10.3390/biom10040496 · Cited by 31
Lambadiari, V., Korakas, E., & Tsimihodimos, V. (2020) · Nutrients · doi:10.3390/nu12082204 · Cited by 32
Fructose Metabolism and Cardiac Metabolic Stress
Annandale, M., Daniels, L. J., Li, X., Neale, J. P. H., Chau, A. H. L., Ambalawanar, H. A., James, S. L., Koutsifeli, P., Delbridge, L. M. D., & Mellor, K. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695486 · Cited by 31
HDL and Lifestyle Interventions
Escolá‐Gil, J. C., Julve, J., Griffin, B. A., Freeman, D. J., & Blanco‐Vaca, F. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_18 · Cited by 35
Sugars and Health Controversies: What Does the Science Say?
Rippe, J. M., & Angelopoulos, T. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.007195 · Cited by 30
Dietary sugars: a fat difference
Hofmann, S. M., & Tschöp, M. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39332 · Cited by 29
Lastra, G., Manrique, C. M., Jia, G., Aroor, A. R., Hayden, M. R., Barron, B. J., Niles, B. J., Padilla, J., & Sowers, J. R. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00483.2016 · Cited by 31
Băbțan, A.-M., Ilea, A., Boşca, A. B., Crişan, M., Petrescu, N. B., Collino, M., Sainz, R. M., Gerlach, J. Q., & Câmpian, R. S. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0448 · Cited by 30
Gumede, N. M., Lembede, B. W., Nkomozepi, P., Brooksbank, R. L., Erlwanger, K. H., & Chivandi, E. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0295 · Cited by 32
Ma, J., Karlsen, M. C., Chung, M., Jacques, P. F., Saltzman, E., Smith, C. E., Fox, C. S., & McKeown, N. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuv047 · Cited by 28
Metabolic Effects of Selected Conventional and Alternative Sweeteners: A Narrative Review
Teysseire, F., Bordier, V., Beglinger, C., Wölnerhanssen, B. K., & Meyer‐Gerspach, A. C. (2024) · Nutrients · doi:10.3390/nu16050622 · Cited by 33
Shirakawa, T., Nakajima, K., Shimomura, Y., Kobayashi, J., Stanhope, K. L., Havel, P. J., Machida, T., Sumino, H., & Murakami, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.020 · Cited by 29
Self-citationSeki, K., Kitade, M., Nishimura, N., Kaji, K., Asada, K., Namisaki, T., Moriya, K., Kawaratani, H., Okura, Y., Takaya, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25587 · Cited by 29
Added Sugar Intake is Associated with Blood Pressure in Older Females
Mansoori, S., Kushner, N., Suminski, R. R., Jr., Farquhar, W. B., & Chai, S. C. (2019) · Nutrients · doi:10.3390/nu11092060 · Cited by 31
Hu, G., Xu, L., Ma, Y., Kohzuki, M., & Ito, O. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00444.2019 · Cited by 29
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 30
Johnson, R. J., Wilson, W. L., Bland, S. T., & Lanaspa, M. A. (2020) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2020.09.006 · Cited by 30
An Exploration of the Role of Sugar-Sweetened Beverage in Promoting Obesity and Health Disparities
Sigala, D. M., & Stanhope, K. L. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00421-x · Cited by 33
Self-citationWu, A. J., Aris, I. M., Rifas‐Shiman, S. L., Oken, E., Taveras, E. M., & Hivert, M. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab043 · Cited by 28
Kanbay, M., Şentürk, B. G., Ertuğlu, L. A., Dağel, T., Afşar, B., İncir, S., Baygül, A., Covic, A. C., Andrés-Hernando, A., Sánchez‐Lozada, L. G., et al. (2021) · Nutrients · doi:10.3390/nu13061916 · Cited by 29
Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
Ristić-Medić, D., Bajerska, J., & Vučić, V. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i27.3314 · Cited by 31
Human brown adipose tissue is not enough to combat cardiometabolic diseases
Carpentier, A. C., & Blondin, D. P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci175288 · Cited by 29
The impact of taxing sugar-sweetened beverages on diabetes: a critical review
Peñalvo, J. L. (2024) · Diabetologia · doi:10.1007/s00125-023-06064-6 · Cited by 31
Saito, H., Kagaya, M., Suzuki, M., Yoshida, A., & Naito, M. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17301 · Cited by 28
Liu, L., Yang, M., Lin, X., Li, Y., Liu, C., Yang, Y., Yamahara, J., Wang, J., & Li, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.10.020 · Cited by 28
Urinary fructose: a potential biomarker for dietary fructose intake in children
Johner, S. A., Libuda, L., Shi, L., Retzlaff, A. A., Joslowski, G., & Remer, T. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.160 · Cited by 30
Fructose, Exercise, and Health
Johnson, R. J., & Murray, R. D. (2010) · Current Sports Medicine Reports · doi:10.1249/jsr.0b013e3181e7def4 · Cited by 31
Baena, M., Sangüesa, G., Hutter, N., Beltrán, J. M. G., Sánchez, R. M., Roglans, N., Alegret, M., & Laguna, J. C. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.015 · Cited by 32
ter Horst, K. W., Gilijamse, P. W., Demirkıran, A., van Wagensveld, B. A., Ackermans, M. T., Verheij, J., Romijn, J. A., Nieuwdorp, M., Maratos–Flier, E., Herman, M. A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.014 · Cited by 31
Kovačević, S., Brkljačić, J. M., Matić, G. M., & Elaković, I. (2018) · Neuroendocrinology · doi:10.1159/000496391 · Cited by 28
Ramli, E. S. M., Sukalingam, K., Kamaruzzaman, M. A., Soelaiman, I. N., Pang, K.-L., & Chin, K. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291828 · Cited by 31
Fructose and liver function – is this behind nonalcoholic liver disease?
Jin, R., & Vos, M. B. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000203 · Cited by 32
Xie, C., Yuan, Y., Wang, Y., Qi, C., Wang, W., An, C., Aikepaer, A., Zhang, Y., Zhang, G., Feng, X., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00673-5 · Cited by 32
PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation
Barroso, E., Rodríguez‐Rodríguez, R., Chacón, M. R., Maymó‐Masip, E., Ferrer‐Font, L., Salvadó, L., Salmerón, E., Wabistch, M., Palomer, X., Vendrell, J. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.010 · Cited by 29
Chavushyan, V. A., Սիմոնյան, Կ. Վ., Simonyan, R. M., Isoyan, A. S., Simonyan, G. M., Babakhanyan, M. A., Hovhannisyian, L. E., Nahapetyan, K. H., Avetisyan, L. G., & Simonyan, M. A. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2049-9 · Cited by 29
Ekta, Gupta, M., Kaur, A., Singh, T. G., & Bedi, O. (2020) · Inflammation Research · doi:10.1007/s00011-020-01373-7 · Cited by 29
Udumula, M. P., Mangali, S., Kalra, J., Dasari, D., Goyal, S., Krishna, V., Bollareddy, S. R., Sriram, D., Dhar, A., & Bhat, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-92345-2 · Cited by 31
IRE1 impairs insulin signaling transduction of fructose-fed mice via JNK independent of excess lipid
Sun, R., Wang, H., Zeng, X., Chan, S. M. H., Li, S., Jo, E., Leung, S.-L., Molero, J. C., & Ye, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.017 · Cited by 29
Machida, T., Miyashita, K., Sone, T., Tanaka, S., Nakajima, K., Saito, M., Stanhope, K. L., Havel, P. J., Sumino, H., & Murakami, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.016 · Cited by 27
Self-citationvan Baak, M. A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0045 · Cited by 34
Zheng, J., Peng, C. X., Ai, Y., Wang, H., Xiao, X., & Li, J. (2016) · Nutrients · doi:10.3390/nu8010055 · Cited by 27
Similarities and interactions between the ageing process and high chronic intake of added sugars
Gatineau, E., Polakof, S., Dardevet, D. P., & Mosoni, L. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000051 · Cited by 29
Ibarra‐Reynoso, L. D. R., Lemus, H. L. L., Garay‐Sevilla, M. E., & Malacara, J. M. (2017) · Obesity Facts · doi:10.1159/000476069 · Cited by 29
Fructose-induced stress signaling in the liver involves methylglyoxal
Wei, Y., Wang, D., Moran, G., Estrada, A. L., & Pagliassotti, M. J. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-32 · Cited by 27
Morimoto, N., Kasuga, C., Tanaka, A., Kamachi, K., Ai, M., Urayama, K. Y., & Tanaka, A. (2018) · British Journal of Nutrition · doi:10.1017/s0007114517003725 · Cited by 26
“Because differential effects of these carbohydrates on metabolic disturbances have been demonstrated((48)), this topic merits further investigation in future studies.”
BackgroundSelf-citationChan, S. M. H., Zeng, X., Sun, R., Jo, E., Zhou, X., Wang, H., Li, S., Xu, A., Watt, M. J., & Ye, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.005 · Cited by 27
Carran, E. L., White, S. J., Reynolds, A. N., Haszard, J. J., & Venn, B. J. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.112 · Cited by 27
Dietary Sources of Fructose and Its Association with Fatty Liver in Mexican Young Adults
Cantoral, A., Contreras‐Manzano, A., Luna-Villa, L. C., Batis, C., Roldán-Valadéz, E., Ettinger, A. S., Mercado, A., Peterson, K. E., Téllez‐Rojo, M. M., & Rivera, J. Á. (2019) · Nutrients · doi:10.3390/nu11030522 · Cited by 27
Chiu, S., Siri‐Tarino, P. W., Bergeron, N., Suh, J. H., & Krauss, R. M. (2020) · Nutrients · doi:10.3390/nu12020405 · Cited by 27
Self-citationLee, G., Han, J. H., Maeng, H. J., & Lim, S. K. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes19042 · Cited by 28
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides
Santos‐Báez, L. S., & Ginsberg, H. N. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000756 · Cited by 26
Attia, H., Albekairi, N. A., Albdeirat, L., Soliman, A., Rajab, R., Alotaibi, H., Ali, R., & Badr, A. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9479456 · Cited by 26
Serum uric acid and metabolic risk
Richette, P., & Pérez-Ruiz, F. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.790801 · Cited by 27
Putakala, M., Gujjala, S., Nukala, S., & Desireddy, S. (2017) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-017-2461-0 · Cited by 26
Fructose and prostate cancer: toward an integrated view of cancer cell metabolism
Carreño, D. V., Corro, N. B., Torres-Estay, V. A., Véliz, L. P., Rodrigo Jaimovich, F., Cisternas, P., Francisco, I. F. S., Sotomayor, P. C., Tanasova, M., Inestrosa, N. C., et al. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0072-7 · Cited by 26
Gender- and Age-Specific Associations between Visceral Obesity and Renal Function Impairment
Tsao, Y.-C., Chen, J., Yeh, W.-C., & Li, W.-C. (2019) · Obesity Facts · doi:10.1159/000496626 · Cited by 31
Hieronimus, B., Griffen, S. C., Keim, N. L., Bremer, A. A., Berglund, L., Nakajima, K., Havel, P. J., & Stanhope, K. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070913 · Cited by 28
Self-citationZhu, Z., He, Y., Wang, Z., He, X., Zang, J., Guo, C., Jia, X., Ren, Y., Shan, C., Sun, J., et al. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12634 · Cited by 27
DiNicolantonio, J. J., & O’Keefe, J. H. (2017) · Open Heart · doi:10.1136/openhrt-2017-000729 · Cited by 30
Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer
Li, Z., Fan, X., Gao, F., Pan, S., Ma, X., Cheng, H., Nakatsukasa, H., Zhang, W., & Zhang, D. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00287-2 · Cited by 33
Self-citationMechanisms of Simple Hepatic Steatosis
Matherly, S. C., & Puri, P. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.005 · Cited by 27
Mao, T., Sun, Y., Xu, X., & He, K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000234 · Cited by 27
Dietary contributors to hypertension in adults reviewed
McCartney, D. M. A., Byrne, D., & Turner, M. J. (2014) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-014-1181-5 · Cited by 26
Coello, S. D., de León, A. C., Pérez, M. D. C. R., Álamo, C. B., Fernández, L. C., González, D. A., Yanes, J. G., Hernández, A. G., Díaz, B. B., & Aguirre‐Jaime, A. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0110-2 · Cited by 29
Clinical Research Strategies for Fructose Metabolism
Laughlin, M. R., Bantle, J. P., Havel, P. J., Parks, E. J., Klurfeld, D. M., Teff, K. L., & Maruvada, P. (2014) · Advances in Nutrition · doi:10.3945/an.113.005249 · Cited by 26
Self-citationContreras, M., Blandón, E. Z., Persson, L. Å., & Ekström, E. (2014) · Maternal and Child Nutrition · doi:10.1111/mcn.12144 · Cited by 25
Crichton, G. E., Elias, M. F., & Torres, R. V. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516000325 · Cited by 27
Thomson, N., Worsley, A., Wang, W., Sarmugam, R., Pham, Q. T., & Februhartanty, J. (2017) · Food Quality and Preference · doi:10.1016/j.foodqual.2017.04.003 · Cited by 27
Butler, A. A., Price, C. A., Graham, J. L., Stanhope, K. L., King, S. M., Hung, Y.-H., Sethupathy, P., Wong, S. C., Hamilton, J., Krauss, R. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m089508 · Cited by 25
Self-citationProcesses exacerbating apoptosis in non-alcoholic steatohepatitis
Afonso, M. B., Castro, R. E., & Rodrigues, C. M. P. (2019) · Clinical Science · doi:10.1042/cs20190068 · Cited by 27
Johnson, L. K., Holven, K. B., Nordstrand, N., Mellembakken, J. R., Tanbo, T., & Hjelmesæth, J. (2015) · Endocrine Connections · doi:10.1530/ec-15-0047 · Cited by 24
Nikolaou, K. C., Godbersen, S., Manoharan, M., Wieland, S. F., Heim, M. H., & Stoffel, M. (2023) · JCI Insight · doi:10.1172/jci.insight.164694 · Cited by 25
Durán‐Agüero, S., Piña, E. C., & Pérez, M. A. (2012) · PubMed · doi:10.3305/nh.2012.27.4.5859 · Cited by 43
Gout and diabetes: a common combination
Collier, A., Stirling, A., Cameron, L., Hair, M. D., & Crosbie, D. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133691 · Cited by 25
Rivera, D. S., Lindsay, C. B., Codocedo, J. F., Carreño, L. E., Cabrera, D., Arrese, M. A., Vio, C. P., Bozinovic, F., & Inestrosa, N. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0969-0 · Cited by 28
Sangüesa, G., Roglans, N., Montañés, J. C., Baena, M., Velázquez, A. M., Sánchez, R. M., Alegret, M., & Laguna, J. C. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800777 · Cited by 24
Bebidas azucaradas, más que un simple refresco
Paulo Silva, O., & Durán‐Agüero, S. (2014) · Revista chilena de nutrición · doi:10.4067/s0717-75182014000100013 · Cited by 42
Metadata
- Authors
- Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
- Affiliations
- University of California, Davis (US)
- University of California, San Francisco (US)
- United States Department of Agriculture (US)
- Touro University California (US)
- UCSF Benioff Children's Hospital (US)
- Tufts University (US)
- KineMed (United States) (US)
- VA Northern California Health Care System (US)
- Corresponding author
- Havel, Peter J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-05-01
- Volume
- 119
- Issue
- 5
- Pages
- 1322-1334
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2673878
- OpenAlex
- W2146966453
- Cited by
- 1,765
- References
- 86
- Citations by year
- 2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
- FWCI
- 74.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association (UL1 RR024146)
- U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- American College of Radiology Imaging Network
- School of Veterinary Medicine, University of California, Davis
- KineMed
- Novo Nordisk
- Otsuka Pharmaceutical
- National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
- University of California, Davis (95616, RR024146, UL1 RR024146)
- Agricultural Research Service (5306‐51530‐016‐00D)
- National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
- National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
- National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
- MeSH terms
- Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.